- Report
- February 2026
- 244 Pages
Asia Pacific
From €5348EUR$5,995USD£4,597GBP
- Report
- January 2026
- 96 Pages
Europe
From €3523EUR$3,950USD£3,029GBP
- Report
- January 2026
- 85 Pages
Asia Pacific
From €3523EUR$3,950USD£3,029GBP
- Report
- January 2026
- 80 Pages
North America
From €3077EUR$3,450USD£2,646GBP
- Report
- July 2025
- 475 Pages
Global
From €4416EUR$4,950USD£3,796GBP
- Report
- February 2025
- 292 Pages
Global
From €4416EUR$4,950USD£3,796GBP
- Report
- July 2023
- 104 Pages
Global
From €4148EUR$4,650USD£3,566GBP
- Report
- May 2022
- 150 Pages
Global
From €4906EUR$5,500USD£4,218GBP
- Report
- October 2025
- 90 Pages
Brazil
From €3523EUR$3,950USD£3,029GBP
- Report
- August 2025
- 123 Pages
Europe
From €4416EUR$4,950USD£3,796GBP
- Report
- August 2025
- 181 Pages
Global
From €3162EUR$3,545USD£2,719GBP
€3514EUR$3,939USD£3,021GBP
- Report
- August 2025
- 183 Pages
Global
From €3162EUR$3,545USD£2,719GBP
€3514EUR$3,939USD£3,021GBP
- Report
- August 2025
- 185 Pages
Global
From €3162EUR$3,545USD£2,719GBP
€3514EUR$3,939USD£3,021GBP
- Report
- August 2025
- 188 Pages
Global
From €3162EUR$3,545USD£2,719GBP
€3514EUR$3,939USD£3,021GBP
- Report
- August 2025
- 195 Pages
Global
From €3162EUR$3,545USD£2,719GBP
€3514EUR$3,939USD£3,021GBP
- Report
- August 2025
- 192 Pages
Global
From €3162EUR$3,545USD£2,719GBP
€3514EUR$3,939USD£3,021GBP
- Report
- August 2025
- 182 Pages
Global
From €3162EUR$3,545USD£2,719GBP
€3514EUR$3,939USD£3,021GBP
- Report
- August 2025
- 188 Pages
Global
From €3162EUR$3,545USD£2,719GBP
€3514EUR$3,939USD£3,021GBP
- Report
- September 2025
- 87 Pages
India
From €3122EUR$3,500USD£2,684GBP
- Report
- August 2025
- 185 Pages
Global
From €4014EUR$4,500USD£3,451GBP

Non-invasive ventilation (NIV) is a type of respiratory device used to treat patients with breathing difficulties. It is a form of mechanical ventilation that does not require an endotracheal tube or tracheostomy. NIV is used to treat a variety of respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea. It can also be used to treat acute respiratory failure, such as acute exacerbations of COPD or asthma. NIV is used to improve oxygenation, reduce the work of breathing, and improve patient comfort.
NIV is typically delivered through a face mask or nasal mask, which is connected to a ventilator. The ventilator delivers a set of breaths at a set rate and pressure. The patient can also trigger additional breaths by taking a deep breath or coughing. NIV can be used in both the hospital and home settings.
NIV is a growing market, with a variety of companies offering products and services. Some of the major players in the market include Philips Respironics, ResMed, Fisher & Paykel Healthcare, and Vyaire Medical. Show Less Read more